{"title": "COVID-19 tracker: Hetero's generic version of Paxlovid becomes first endorsed by WHO", "author": "Zoey Becker; Kevin Dunleavy; Fraiser Kansteiner; Angus Liu", "url": "https://www.fiercepharma.com/pharma/covid-19-tracker-europes-chmp-gives-thumbs-moderna-pfizer-boosters-positive-results-vaxarts", "hostname": "fiercepharma.com", "description": "The WHO has signed off on its first generic version of Paxlovid, granting prequalification to Hetero of India. | The WHO has signed off on its first generic version of Paxlovid, granting prequalification to Hetero of India. A study shows that a booster dose of an mRNA vaccine from Moderna or Pfizer produces a more durable antibody response. Plus more.", "sitename": "FiercePharma", "date": "2022-12-27", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}